Prokidney Corp.
PROK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850270
In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $99.5M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Prokidney Corp. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +9 vs. Q3 2022
- Shares held
- 31.4M
- +15.4M (+96.2%) vs. Q3 2022
- Total value
- $215.6M
- +$71.3M (+49.4%) vs. Q3 2022
- New holders
- 11
- 11 more added
- Sold out
- 2
- 1 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PROK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $99.5M |
| Q1 2026 | 71 | $78.1M |
| Q4 2025 | 63 | $96.2M |
| Q3 2025 | 56 | $83.4M |
| Q2 2025 | 56 | $20.9M |
| Q1 2025 | 69 | $42.0M |
| Q4 2024 | 74 | $86.1M |
| Q3 2024 | 71 | $94.3M |
| Q2 2024 | 65 | $98.8M |
| Q1 2024 | 55 | $44.1M |
| Q4 2023 | 61 | $52.3M |
| Q3 2023 | 67 | $185.4M |
| Q2 2023 | 56 | $445.6M |
| Q1 2023 | 35 | $391.2M |
| Q4 2022 | 27 | $215.6M |
| Q3 2022 | 18 | $144.4M |
| Q2 2022 | 67 | $191.2M |
| Q1 2022 | 80 | $232.0M |
| Q4 2021 | 90 | $227.0M |
| Q3 2021 | 84 | $226.1M |
| Q2 2021 | 71 | $229.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Prokidney Corp.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Social Capital Group LLC | 13,273,000 | $91.1M | 77.68% | +13,273,000 | New |
| Morgan Stanley | 10,947,495 | $75.1M | 0.01% | +595,839+5.8% | Added |
| Suvretta Capital Management, LLC | 3,193,175 | $21.9M | 0.92% | 00.0% | Unchanged |
| Bleichroeder LP | 2,000,000 | $13.7M | 2.98% | 00.0% | Unchanged |
| Brown University | 1,000,000 | $6.86M | 2.87% | +1,000,000 | New |
| BlackRock Inc. | 205,684 | $1.41M | 0.00% | +96,882+89.0% | Added |
| Bank of America Corp | 196,444 | $1.35M | 0.00% | +196,434+1,964,340.0% | Added |
| Vanguard Group Inc | 182,650 | $1.25M | 0.00% | +30,550+20.1% | Added |
| Geode Capital Management, LLC | 132,808 | $911.0K | 0.00% | +30,253+29.5% | Added |
| Swiss National Bank | 74,301 | $509.7K | 0.00% | +74,301 | New |
| State Street Corp | 51,123 | $350.7K | 0.00% | +51,123 | New |
| State of Wisconsin Investment Board | 30,841 | $211.6K | 0.00% | +30,841 | New |
| Northern Trust Corp | 28,072 | $192.6K | 0.00% | +9,370+50.1% | Added |
| California State Teachers Retirement System | 26,686 | $183.1K | 0.00% | +26,686 | New |
| Amundi | 23,822 | $182.2K | 0.00% | +23,822 | New |
| Credit Suisse AG | 21,323 | $146.3K | 0.00% | −21,127−49.8% | Reduced |
| Goldman Sachs Group Inc | 15,722 | $107.9K | 0.00% | +15,722 | New |
| Compagnie Lombard Odier SCmA | 10,500 | $72.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 8,286 | $56.8K | 0.00% | +8,286 | New |
| JPMorgan Chase & Co | 3,367 | $23.0K | 0.00% | +3,367 | New |
| UBS Group AG | 2,638 | $18.1K | 0.00% | +1,845+232.7% | Added |
| Tower Research Capital LLC (TRC) | 2,245 | $15.0K | 0.00% | +1,160+106.9% | Added |
| Royal Bank of Canada | 1,090 | $7.00K | 0.00% | +290+36.3% | Added |
| US Bancorp | 1,000 | $6.86K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 767 | $5.26K | 0.00% | +767 | New |
| Signaturefd, LLC | 105 | $720 | 0.00% | +45+75.0% | Added |
| Wells Fargo & Company | 79 | $542 | 0.00% | +10+14.5% | Added |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −26,500−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −14,603−100.0% | Sold out |